Volume: 1 Issue: 1
Year: 2013, Page: 3-10,
Introduction: Iron deficiency anaemia remains the most common medical disorder in pregnancy in the developing world, with the burden of disease impacting on both the mother and the new born. Packed cells\blood transfusions are associated with complications like both immune and non-immune mediated reactions and blood borne diseases. The safety of sucrose has been demonstrated in previous studies.
Material and Methods: Aprospective, comparative study was conducted in the Department of Obstetrics and Gynaecology, Kakatiya Medical College, Warangal during August 2010 to August 2012. All antenatal women were screened for anaemia and those presenting with moderate to severe anaemia between gestational age of 16-34 weeks were included in the study. These women were randomly selected to study and control groups where for the study group Intravenous Iron Sucrose was given and for control group, packed cell transfusion was given. A detailed history, clinical examination, obstetric examination and investigations were done for these antenatal women and an informed consent was taken.
Results: On an average 80% were in the age group of 15-24 years in both groups. In iron sucrose group, mean Haemoglobin % at baseline 7.1±0.8g/dl, after 1 week 7.9±0.6, after 4 weeks 11±0.5g/dl and at delivery 11.7±0.6 g/dl. Where as in packed cell group, baseline Hb% was 7.0±0.8g/dl, after 1 week 10.2±0.5%g/dl, after 4 weeks 10.3±0.5 g/dl and at delivery 10.2±0.4% g/dl. The mean haematocrit values in iron sucrose group at baseline 20.9±2.5%, after 1 week 25.3±2.2% and 4 weeks 33.6±2.0%. And in packed cell group at baseline 20.8±2.3%, after 1 week 30.0±1.9% and after 4 weeks 30.2±2.0%. The mean ferritin values in Iron sucrose group at baseline and after 4 weeks are 8.9±1.7µg/L and 89.8±6.7µg/L respectively where as in packed cell group, at baseline 8.7±1.8µg/dl and at 4 weeks, 40.1±5.4µg/L. In both groups, with each intervention the improvement in Hb%, haematocrit and ferritin values were statistically significant.
Conclusion: Parental Iron Sucrose is a safe, nontoxic alternative to packed cell transfusion in the management of moderate to severe anaemia complicating pregnancy. Parental iron sucrose therapy has a sustained rise of haemoglobin and haematocrit which persists even after the time of delivery and should be an integral part of management for the patients of moderate to severe anaemia
Keywords: Parenteral Iron Sucrose, packed cell transfusion, anaemia, pregnancy
1. WHO/UNICEF/UNO. Indicators for Assessing Iron Deficiency and Strategies for its Prevention, WHO Draft, Geneva 1996.
2. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, Switzerland : WHO; 2011. P3
3. CDC criteria for anaemia in children and child bearing - aged women. MMWR Morb Mortal Weekly Rep 1989;38:400-4
4. Institute of Medicine, Committee on Nutritional Status during Pregnancy and Lactation. Nutrition during pregnancy. Washington,DC: National Academy Press 1990:272-98.
5. Kalaivani K. Prevalence & consequences of anaemia in pregnancy. Indian J Med Res 2009; 130 : 627-33.
6. Allen LH., Pregnancy and Iron deficiency. Unresolved issue. Nutrition Reviews 1997; 55:91-101.
7. Letsky EA (1995) Erythropoiesis in pregnancy. Journal of Perinatal Medicine 23, 39-45
8. Cook J , Skikine B & Baynes R (1994) from Iron deficiency : The global perspective. In Progres in iron Research, PP. 219-228 [ C Hershko ,editor ]. New York, NY : Plenum Press.
9. WHO (1996) Revised 1990 estimate of maternal mortality. A new approach by WHO and UNICEF. WHO, Geneva, Switzerland
10. ICMR evaluation of the national nutritional anaemia prophylaxis programme. ICMR Task Force Study . New Delhi : Indian Council of Medical Research ; 1989
11. NFHS (2002) India 1998-99 – National Family Health Survey-2 (NFHS-2) Anaemia among women and children . Mumbai : International Institute for Population Sciences; 2000
12. Koller O. The clinical significance of haemodilution during pregnancy. Obstetrics Gynaecology Survey 1982;37:649.
13. J.B. Sharma, Nutritional anaemia during pregnancy in non-industrialized countries, John Studd: vol 15:103-122
14. World Health Organisation. Causes of maternal and child deaths, taking stock of maternal, newborn and child survival 2000–2010 decade report. Geneva: WHO; 11-21.
15. Godfrey KM , Redman CWG, Barker DJP, Osmond C The effect of maternal anaemia and iron deficiency on the ratio of fetal weight to placental weight . Br J Obstet Gynaecol, 1991;98:886 89
16. Barker DJP, Bull AR ,Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. Br Med J 1990 ;301: 259-262
17. Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol 2004 May; 76:74-8.
18. Kamani AA, McMorland GH, Wadsworth LD. Utilization of red blood cell transfusion in an obstetric setting. Am J Obstet Gynecol. 1988; 159:1177-81.
19. Huch R , Breymann C : Anaemia in Pregnancy and Postpartum (ed 1). Zurich Obstetrics Clinic. Bremen, Germany Uni-Med Verlag, 2005;
20. Al – Momen K, Al- Mishary A, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anaemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996; 69;121-124
21. Gravier A, Descargues G, Marpeau L: Comment eviter les transfusions dans le postpartum: interet d'une supplementation martiale par voie intraveineuse. J G Gynecol Obstet Biol Reprod (Paris) 28:77-78, 1999
22. Khalboun Khamaiseh MD, Intravenous Iron Sucrose vs. Blood Transfusion in the Management of Symptomatic Post Partum Iron Deficiency Anaemia Journal of the Royal Medical Servises ; Vol. 18; No. 1 ; March 2011 ; 15-19.
23. Ragip et al. Intravenous Versus Oral Iron for Treatment of Anaemia in Pregnancy; ACOG; VOL. 106, No.6, Dec 2005
Vivekanand A, Kanikireddy S. Parenteral iron sucrose as an alternative to packed cell transfusion in moderate to severe anaemia in pregnancy.Perspectives in medical research 2013; 1: 3-10